Open AccessBurkitt’s Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt’s Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital
Author(s) -
Gerhard Sissolak,
Matthew D. Seftel,
Thomas S. Uldrick,
Tonya Esterhuizen,
Nooroudien Mohamed,
Danie Kotze
Publication year - 2017
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.2015.002378
Subject(s) - vincristine , medicine , cyclophosphamide , prednisone , lymphoma , chop , diffuse large b cell lymphoma , regimen , gastroenterology , chemotherapy , oncology , immunology
Burkitt's lymphoma (BL) is a common HIV-associated lymphoma in South Africa. B-cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma (BL/DLBCL) also occurs in HIV infection. Outcomes of HIV-infected patients with BL or BL/DLBCL in a resource-constrained setting are not defined.